Skip to main content

Table 3 Intraoperative and surgical outcomes

From: Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study

 

Control group (n = 15)

Prehabilitation group (n = 14)

p-value

Surgical approach

 Laparoscopic

2 (13.3)

0 (0)

0.157

 Laparotomic

13 (86.7)

14 (100)

Intestinal resection

1 (6.7)

2 (14.3)

0.501

Epidural anesthesia

11 (73.3)

11 (78.6)

0.742

Surgical time (min) mean ± SD

309.0 ± 76.7

300.0 ± 87.7

0.770

Aletti’s SCS, mean ± SD

5.0 ± 1.2

5.1 ± 2.6

0.927

Intraoperative blood transfusion

8 (53.3)

2 (14.3)

0.027

Intraoperative vasoactive drugs

3 (20.0)

1 (7.1)

0.316

Intraoperative complications

6 (40.0)

2 (14.3)

0.122

 Vascular

3 (20.0)

1 (7.1)

0.316

 Intestinal

2 (13.3)

1 (7.1)

0.584

 Urological

1 (6.7)

1 (7.1)

0.960

 Cardiovascular

0 (0)

0 (0)

-

  1. Data are presented as n (%), unless otherwise specified
  2. SCS surgical complexity score, SD standard deviation